$PNNX News: Pennexx Announces its Smartphone, Tablet and

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
195
$PNNX News: Pennexx Announces its Smartphone, Tablet and Laptop App Development Project and Discusses the Associated Benefits of These Applications

Philadelphia, PA, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pennexx (PNNX) has announced its initiative to creating applications to enhance its current https://yoursocialoffers.com Your Social Offers (YSO) platform.

Pennexx has been developing this application in conjunction with OEM manufacturers to be compatible with Android and Apple IOS smartphones and tablets as well as Microsoft Windows and Google Chrome laptops and tablets.

This application will generate new and exciting opportunities for the YSO brand because it enhances its availability and functionality. The company is working on contracts with OEM manufacturers and resellers to have the software pre-installed (preloaded and bundled) on devices to create an immediate value to shareholders and the company's revenues while creating a unique benefit to users who receive these devices.

By preloading the YSO app on user's devices and the simple click of the YSO icon, they eliminate the need for users to navigate the internet to locate the product themselves. Users will automatically be introduced to YSO and learn about the benefits of the product.

This application will also be made available in the Google and Apple Store, providing a great deal of visibility and easy access to the consumer.

This App will give users more functionality, such as being immediately notified when they are in the vicinity of a YSO merchant, locating products by scanning in-store barcodes, and the ability to search for products, services, and merchants directly from the App.

It will also include features for the user to make redemption and management of coupons easier. Consumers can show a merchant their coupon with a simple click eliminating the need to open an email with the coupon.

The YSO app preloaded on these devices creates more savings for the consumer and more business for merchants. It will increase the number of YSO consumers and increase Pennexx's revenue by increasing sales and licensing fees.

The App will also connect with the YSO debit card so that users can manage their YSO funds, directly receive rewards, and complete purchases directly.

According to Medium.com https://medium.com/@KNOWARTH/9-advantages-of-...ed1e6db0d8, there are nine advantages to a mobile smartphone app as opposed to the responsive website access that YSO currently offers. They include:

Faster access
A more personalized experience
Instant online and offline access, excellent when you may have limited coverage inside a merchant
Utilization of geolocation features
Push notifications keeping the user engaged
Specific branding and design
Increased productivity and reach quicker
More interactive engagement keeping users interested
Advantages with in-app content as well as directing users to website content
YSO is planning to offer social media influencers a direct, trackable link to sharing offers and monetizing their social influence in a real-time manner.

The App will include collecting donations for charities with unique coupons for merchants only available to those who donate.

Users can also have the ability to purchase coupons redeemed with merchants with a system similar to that of GroupOn™.

When YSO makes this App available to all the major platforms, users will benefit from YSO, and YSO should benefit from a tremendous increase in user potential, revenues, and branding.

All of these features, in combination, can have the effect of supercharging YSO's growth.

Vincent Risalvato, CEO of Pennexx, said, "Pennexx has been developing the smartphone app in a confidential manner; however, it is now close enough to being completed to announce to the public. I consider this a major milestone in the company and one that I believe will redefine YSO and Pennexx as a whole. Joining the Apple and Google App Store marketplace will give our consumers and merchants a tremendous tool for growth and savings."

According to Statista.com https://www.statista.com/statistics/322286/gr...downloads/, the GroupOn™ smartphone app was downloaded to devices 200 million times in 2019. Pennexx believes the YSO App represents more value to a consumer than the GroupOn™ App because it hosts additional varieties for the consumers can be rewarded.

For More Information

Pennexx will do their best to openly and publicly answer your questions and concerns via social media on Twitter https://twitter.com/pennexx @pennexx, or you may email investors@pennexx.net.

You may also follow them on Twitter; Ms. Sunny Sweet (@sunnysweettweet) https://twitter.com/sunnysweettweet, Mr. Risalvato (@vrisalvato) https://twitter.com/vrisalvato and Joe Candito (@jcandito) https://twitter.com/jcandito.

About Pennexx Foods Inc.

About Pennexx Foods Inc. (PNNX: OTCMKTS US): Pennexx, through its wholly-owned subsidiaries, is a holding company within the Software/Internet Industry focused on social media, prepaid debit cards, BitGift™, artificial intelligence, targeted marketing, and consumer rewards.

Safe Harbor Act: This release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.

For additional information, you may also visit our website at https://yoursocialoffers.com or https://pennexx.net or call 866-928-6409. Please follow us on Twitter @Pennexx.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 34

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 497

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 17

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 81

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 62

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 493

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

FPI Earnings Preview: Traders Eye EPS and Guidance Impact

Updated Category News Views 158

Farmland Partners (NYSE:FPI) is prepped to drop its quarterly earnings on February 18, 2026, and you better believe traders are already sweating over it. Analysts are throwing out estimates pegging the earnings per share (EPS) at $0.19—now, that's not exactly a home run but it's enough to keep eyes glued to the screens as we await the news. The buzz in the air is thick;...

Continue Reading
Reviva Pharmaceuticals Engages Investors at 2025 Summit

Updated Category News Views 312

Reviva Pharmaceuticals Attending the 2025 Investor Healthcare Summit Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a leader in the biopharmaceutical industry, committed to developing cutting-edge therapies that cater to unmet medical needs. This January, Reviva will have an influential presence at the upcoming Lytham Partners 2025 Investor Healthcare Summit....

Continue Reading
Genpact's Q1 2025 Financial Highlights and Future Outlook

Updated Category News Views 886

Financial Performance Overview for Genpact Genpact Limited (NYSE: G) has reported outstanding net revenues of $1.215 billion for the first quarter of 2025, reflecting a robust growth rate of 7.4% year-over-year, or 8.3% when adjusted for constant currency fluctuations. This growth has been fueled by an impressive performance in its Data-Tech-AI segment, which generated...

Continue Reading
Multinational Investments: How to Reach More Countries

Updated Category Investing Views 706

Global expansion has become a strategic priority for companies seeking long-term growth. Markets mature, local competition intensifies, and consumer expectations evolve quickly. As a result, multinational investments are no longer reserved for massive corporations. Mid-sized and even smaller firms are exploring foreign markets to diversify revenue and increase resilience....

Continue Reading
Nobu Hospitality Unveils Luxury Residential Options in Kraków

Updated Category News Views 126

Nobu Hospitality Expands Its Luxury Footprint Nobu Hospitality is a name synonymous with luxury and refinement in the hospitality industry, expanding its prestigious brand into new territories. One of its latest ventures takes a significant leap into a magnificent city rich in history—Kraków. This development marks a notable milestone as it is Nobu's first residential...

Continue Reading